Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OCO | fcp | 05/03/08 | 4 | 1.4K | |||
|
|||||||
OCO | well hello possums come out of the dark now | 21/12/07 | 5 | 1.3K | |||
|
|||||||
OCO | director buying | 19/12/07 | 0 | 379 | |||
|
|||||||
OCO | changing of the guard | 05/12/07 | 2 | 941 | |||
|
|||||||
OCO | are we about to move up | 21/11/07 | 7 | 1.4K | |||
|
|||||||
OCO | something else to think about | 05/09/07 | 0 | 431 | |||
|
|||||||
OCO | binding agreement signed | 04/09/07 | 16 | 3.5K | |||
|
|||||||
OCO | more buyers | 31/07/07 | 0 | 331 | |||
|
See All Discussions